Europe Cervical Cancer Test Market

1
(No Transcript)
2
Europe Cervical Cancer Test Market, Patients, By
Screening Type (Pap Smear, HPV DNA) (United
Kingdom, France, Germany, Italy, Spain, Sweden,
Switzerland, Norway, Netherlands)
Cervical cancer is one of the most serious public
health issues in Europe. Despite introduction of
vaccination in 21 European countries, still more
than 24 Thousand women have died from cervical
cancer across all over Europe. Cervical cancer
incidence rate in Europe was 10.6 per 100,000
women population. Germany, France and United
Kingdom are top three dominating countries in the
Europe cervical cancer market in 2015. Europe
Cervical Cancer Test Market, Patients, By
Screening Type (Pap Smear, HPV DNA) (United
Kingdom, France, Germany, Italy, Spain, Sweden,
Switzerland, Norway, Netherlands) is 119 Page
market research report with 115 Figures and 2
Tables published by Renub Research.

3
Continue (www.renub.com)
All the 9 countries in the report have been
studied from 3 viewpoints.   Cervical Cancer Test
Market, Population Mortality   Cervical Cancer
Test Population (2008-2020) Pap Smear Test
Population Forecast HPV DNA Test Population
Forecast   Cervical Cancer Mortality Population
(2001-2011)   Cervical Cancer Test Market
(2008-2020) Pap Smear Test Market Forecast HPV
DNA Test Market Forecast

4
Continue (www.renub.com)

• 9 Countries studied in the report are as follows
•  
• United Kingdom
• France
• Germany
• Italy
• Spain
• Sweden
• Switzerland
• Norway
• Netherlands

5
Continue (www.renub.com)

Data Sources   This report is built using data
and information sourced from proprietary
databases, primary and secondary research and
in-house analysis by Renub Research team of
industry experts.   Primary sources include
industry surveys and telephone interviews with
industry experts.   Secondary sources
information and data has been collected from
various printable and non-printable sources like
search engines, News websites, Government
Websites, Trade Journals, White papers,
Government Agencies, Magazines, Newspapers, Trade
associations, Books, Industry Portals, Industry
Associations and access to more than 1000 paid
databases.
6
Continue (www.renub.com)

• Table of Contents
• 1. Executive Summary
• 2. Europe Cervical Cancer Test (Screening)
  Population Forecast
• 3. Europe Cervical Cancer Test (Screening) Market
  Forecast
• 3.1 Europe Cervical Cancer Pap Smear Test
  (Screening) Market Forecast
• 3.2 Europe Cervical Cancer HPV DNA Test
  (Screening) Market Forecast
• 4. Europe Cervical Cancer Test (Screening)
  Population Share, Market Share Forecast
• 4.1 Europe Cervical Cancer Test (Screening)
  Population Share Forecast
• 4.2 Europe Cervical Cancer Test (Screening)
  Market Share Forecast

7
Continue (www.renub.com)

• 4.3 Europe Cervical Cancer Pap Smear Test
  (Screening) Market Share Forecast
• 4.4 Europe Cervical Cancer HPV DNA Test
  (Screening) Market Share Forecast
• 5. United Kingdom Cervical Cancer Test Analysis
• 5.1 United Kingdom Cervical Cancer Test
  (Screening) Population
• 5.1.1 United Kingdom Cervical Cancer Pap Smear
  Test Population Forecast
• 5.1.2 United Kingdom Cervical Cancer HPV DNA Test
  Population Forecast
• 5.2 United Kingdom Cervical Cancer Deaths
• 5.3 United Kingdom Cervical Cancer Test
  (Screening) Analysis
• 5.3.1 United Kingdom Cervical Cancer Test Market
  Forecast
• 5.3.2 United Kingdom Pap Smear Test Market
  Forecast
• 5.3.3 United Kingdom HPV DNA Test Market
  Forecast

8
Continue (www.renub.com)

• 6. France Cervical Cancer Test Analysis
• 6.1 France Cervical Cancer Test (Screening)
  Population
• 6.1.1 France Cervical Cancer Pap Smear Test
  Population Forecast
• 6.1.2 France Cervical Cancer HPV DNA Test
  Population Forecast
• 6.2 France Cervical Cancer Mortality
• 6.3 France Cervical Cancer Test (Screening)
  Analysis
• 6.3.1 France Cervical Cancer Test Market
  Forecast
• 6.3.2 France Pap Smear Test Market Forecast
• 6.3.3 France HPV DNA Test Market Forecast
• 7. Germany Cervical Cancer Test Analysis
• 7.1 Germany Cervical Cancer Test (Screening)
  Population
• 7.1.1 Germany Cervical Cancer Pap Smear Test
  Population Forecast
• 7.1.2 Germany Cervical Cancer HPV DNA Test
  Population Forecast
• 7.2 Germany Cervical Cancer Mortality

9
Continue (www.renub.com)

• 7.3 Germany Cervical Cancer Test (Screening)
  Market
• 7.3.1 Germany Cervical Cancer Test Market
  Forecast
• 7.3.2 Germany Pap Smear Test Market Forecast
• 7.3.3 Germany HPV DNA Test Market Forecast
• 8. Italy Cervical Cancer Test Analysis
• 8.1 Italy Cervical Cancer Test (Screening)
  Population
• 8.1.1 Italy Cervical Cancer Pap Smear Test
  Population Forecast
• 8.1.2 Italy Cervical Cancer HPV DNA Test
  Population Forecast
• 8.2 Italy Cervical Cancer Mortality
• 8.3 Italy Cervical Cancer Test (Screening) Market
• 8.3.1 Italy Cervical Cancer Test Market
  Forecast
• 8.3.2 Italy Pap Smear Test Market Forecast
• 8.3.3 Italy HPV DNA Test Market Forecast

10
Continue (www.renub.com)

• 9. Spain Cervical Cancer Test Analysis
• 9.1 Spain Cervical Cancer Test (Screening)
  Population
• 9.1.1 Spain Cervical Cancer Pap Smear Test
  Population Forecast
• 9.1.2 Spain Cervical Cancer HPV DNA Test
  Population Forecast
• 9.2 Spain Cervical Cancer Mortality
• 9.3 Spain Cervical Cancer Test (Screening) Market
• 9.3.1 Spain Cervical Cancer Test Market
  Forecast
• 9.3.2 Spain Pap Smear Test Market Forecast
• 9.3.3 Spain HPV DNA Test Market Forecast
• 10. Sweden Cervical Cancer Test Analysis
• 10.1 Sweden Cervical Cancer Test (Screening)
  Population
• 10.1.1 Sweden Cervical Cancer Pap Smear Test
  Population Forecast
• 10.1.2 Sweden Cervical Cancer HPV DNA Test
  Population Forecast
• 10.2 Sweden Cervical Cancer Mortality

11
Continue (www.renub.com)

• 10.3 Sweden Cervical Cancer Test (Screening)
  Market
• 10.3.1 Sweden Cervical Cancer Test Market
  Forecast
• 10.3.2 Sweden Pap Smear Test Market Forecast
• 10.3.3 Sweden HPV DNA Test Market Forecast
• 11. Switzerland Cervical Cancer Test Analysis
• 11.1 Switzerland Cervical Cancer Test (Screening)
  Population
• 11.1.1 Switzerland Cervical Cancer Pap Smear Test
  Population Forecast
• 11.1.2 Switzerland Cervical Cancer HPV DNA Test
  Population Forecast
• 11.2 Switzerland Cervical Cancer Mortality
• 11.3 Switzerland Cervical Cancer Test (Screening)
  Market
• 11.3.1 Switzerland Cervical Cancer Test Market
  Forecast
• 11.3.2 Switzerland Pap smear Test Market
  Forecast
• 11.3.3 Switzerland HPV DNA Test Market Forecast

12
Continue (www.renub.com)

• 12. Norway Cervical Cancer Test Analysis
• 12.1 Norway Cervical Cancer Test (Screening)
  Population
• 12.1.1 Norway Cervical Cancer Pap Smear Test
  Population Forecast
• 12.1.2 Norway Cervical Cancer HPV DNA Test
  Population Forecast
• 12.2 Norway Cervical Cancer Mortality
• 12.3 Norway Cervical Cancer Test (Screening)
  Market
• 12.3.1 Norway Cervical Cancer Test Market
  Forecast
• 12.3.2 Norway Pap Smear Test Market Forecast
• 12.3.3 Norway HPV DNA Test Market Forecast
• 13. Netherlands Cervical Cancer Test Analysis
• 13.1 Netherlands Cervical Cancer Test (Screening)
  Population
• 13.1.1 Netherlands Cervical Cancer Pap Smear Test
  Population Forecast
• 13.1.2 Netherlands Cervical Cancer HPV DNA Test
  Population Forecast

13
Continue (www.renub.com)

• 13.2 Netherlands Cervical Cancer Mortality
• 13.3 Netherlands Cervical Cancer Test (Screening)
  Market
• 13.3.1 Netherlands Cervical Cancer Test Market
  Forecast
• 13.3.2 Netherlands Pap Smear Test Market
  Forecast
• 13.3.3 Netherlands HPV DNA Test Market Forecast
• 14. Cervical Cancer Test Market Growth Drivers
• 14.1 Rising Cases of Teenage Sexual Cases
  Globally
• 14.2 Huge Prevalence of HPV Infected Patients
  Globally
• 15. Challenges in Cervical Cancer Test Market
• 15.1 Introduction of HPV Vaccination Programs
  Globally

14
Continue (www.renub.com)

• List of Figures
• Figure 2 1 Europe Cervical Cancer Test
  Population (Million), 2008 2015
• Figure 2 2 Europe Forecast for Cervical Cancer
  Test Population (Million), 2016 2020
• Figure 3 1 Europe Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 3 2 Europe Forecast for Cervical Cancer
  Test Market (Million US), 2016 2020
• Figure 3 3 Europe Cervical Cancer Pap Smear
  Test Market (Million US), 2008 2015
• Figure 3 4 Europe Forecast for Cervical Cancer
  Pap Smear Test Market (Million US), 2016 2020
• Figure 3 5 Europe Cervical Cancer HPV DNA Test
  Market (Million US), 2008 2015
• Figure 3 6 Europe Forecast for Cervical Cancer
  HPV DNA Test Market (Million US), 2016 2020

15
Continue (www.renub.com)

• Figure 4 1 Europe Cervical Cancer Test
  Population Share (Percent), 2008 2015
• Figure 4 2 Europe Forecast for Cervical Cancer
  Test Population Share (Percent), 2016 2020
• Figure 4 3 Europe Cervical Cancer Test Market
  Share (Percent), 2008 2015
• Figure 4 4 Europe Forecast for Cervical Cancer
  Test Market Share (Percent), 2016 2020
• Figure 4 5 Europe Cervical Cancer Pap Smear
  Test Market Share (Percent), 2008 2015
• Figure 4 6 Europe Forecast for Cervical Cancer
  Pap Smear Test Market Share (Percent), 2016
  2020
• Figure 4 7 Europe Cervical Cancer HPV DNA Test
  Market Share (Percent), 2008 2015
• Figure 4 8 Europe Forecast for Cervical Cancer
  HPV DNA Test Market Share (Percent), 2016 2020

16
Continue (www.renub.com)

• Figure 5 1 United Kingdom Cervical Cancer Pap
  Smear Test Population (Thousand), 2008 2015
• Figure 5 2 United Kingdom Forecast for
  Cervical Cancer Pap Smear Test Population
  (Thousand), 2016 2020
• Figure 5 3 United Kingdom Cervical Cancer HPV
  DNA Test Population (Thousand), 2008 2015
• Figure 5 4 United Kingdom Forecast for
  Cervical Cancer HPV DNA Test Population
  (Thousand), 2016 2020
• Figure 5 5 United Kingdom Cervical Cancer
  Deaths (Number), 2001 2011
• Figure 5 6 United Kingdom Cervical Cancer Test
  Market (Million US), 2008 2015
• Figure 5 7 United Kingdom Forecast for
  Cervical Cancer Test Market (Million US), 2016
  2020
• Figure 5 8 United Kingdom Pap Smear Test
  Market (Million US), 2008 2015
• Figure 5 9 United Kingdom Forecast for Pap
  Smear Test Market (Million US), 2016 2020
• Figure 5 10 United Kingdom HPV DNA Test Market
  (Million US), 2008 2015
• Figure 5 11 United Kingdom Forecast for HPV
  DNA Test Market (Million US), 2016 2020

17
Continue (www.renub.com)

• Figure 6 1 France Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 6 2 France Forecast for Cervical Cancer
  Pap Smear Test Population (Thousand), 2016 2020
• Figure 6 3 France Cervical Cancer HPV DNA Test
  Population (Thousand), 2008 2015
• Figure 6 4 France Forecast for Cervical Cancer
  HPV DNA Test Population (Thousand), 2016 2020
• Figure 6 5 France Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 6 6 France Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 6 7 France Forecast for Cervical Cancer
  Test Market (Million US), 2016 2020
• Figure 6 8 France Pap Smear Test Market
  (Million US), 2008 2015
• Figure 6 9 France Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 6 10 France HPV DNA Test Market
  (Million US), 2008 2015
• Figure 6 11 France Forecast for HPV DNA Test
  Market (Million US), 2016 2020

18
Continue (www.renub.com)

• Figure 7 1 Germany Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 7 2 Germany Forecast for Cervical
  Cancer Pap Smear Test Population (Thousand), 2016
  2020
• Figure 7 3 Germany Cervical Cancer HPV DNA
  Test Population (Thousand), 2005 2013
• Figure 7 4 Germany Forecast for Cervical
  Cancer HPV DNA Test Population (Thousand), 2014
  2020
• Figure 7 5 Germany Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 7 6 Germany Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 7 7 Germany Forecast for Cervical
  Cancer Test Market (Million US), 2016 2020
• Figure 7 8 Germany Pap Smear Test Market
  (Million US), 2008 2015
• Figure 7 9 Germany Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 7 10 Germany HPV DNA Test Market
  (Million US), 2008 2015
• Figure 7 11 Germany Forecast for HPV DNA Test
  Market (Million US), 2016 2020

19
Continue (www.renub.com)

• Figure 8 1 Italy Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 8 2 Italy Forecast for Cervical Cancer
  Pap Smear Test Population (Thousand), 2016 2020
• Figure 8 3 Italy Cervical Cancer HPV DNA Test
  Population (Thousand), 2008 2015
• Figure 8 4 Italy Forecast for Cervical Cancer
  HPV DNA Test Population (Thousand), 2016 2020
• Figure 8 5 Italy Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 8 6 Italy Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 8 7 Italy Forecast for Cervical Cancer
  Test Market (Million US), 2016 2020
• Figure 8 8 Italy Pap Smear Test Market
  (Million US), 2008 2015
• Figure 8 9 Italy Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 8 10 Italy HPV DNA Test Market (Million
  US), 2008 2015
• Figure 8 11 Italy Forecast for HPV DNA Test
  Market (Million US), 2016 2020

20
Continue (www.renub.com)

• Figure 9 1 Spain Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 9 2 Spain Forecast for Cervical Cancer
  Pap Smear Test Population (Thousand), 2016 2020
• Figure 9 3 Spain Cervical Cancer HPV DNA Test
  Population (Thousand), 2008 2015
• Figure 9 4 Spain Forecast for Cervical Cancer
  HPV DNA Test Population (Thousand), 2016 2020
• Figure 9 5 Spain Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 9 6 Spain Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 9 7 Spain Forecast for Cervical Cancer
  Test Market (Million US), 2016 2020
• Figure 9 8 Spain Pap Smear Test Market
  (Million US), 2008 2015
• Figure 9 9 Spain Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 9 10 Spain HPV DNA Test Market (Million
  US), 2008 2015
• Figure 9 11 Spain Forecast for HPV DNA Test
  Market (Million US), 2016 2020

21
Continue (www.renub.com)

• Figure 10 1 Sweden Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 10 2 Sweden Forecast for Cervical
  Cancer Pap Smear Test Population (Thousand), 2016
  2020
• Figure 10 3 Sweden Cervical Cancer HPV DNA
  Test Population (Thousand), 2008 2015
• Figure 10 4 Sweden Forecast for Cervical
  Cancer HPV DNA Test Population (Thousand), 2016
  2020
• Figure 10 5 Sweden Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 10 6 Sweden Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 10 7 Sweden Forecast for Cervical
  Cancer Test Market (Million US), 2016 2020
• Figure 10 8 Sweden Pap Smear Test Market
  (Million US), 2008 2015
• Figure 10 9 Sweden Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 10 10 Sweden HPV DNA Test Market
  (Million US), 2008 2015
• Figure 10 11 Sweden Forecast for HPV DNA Test
  Market (Million US), 2016 2020

22
Continue (www.renub.com)

• Figure 11 1 Switzerland Cervical Cancer Pap
  Smear Test Population (Thousand), 2008 2015
• Figure 11 2 Switzerland Forecast for Cervical
  Cancer Pap Smear Test Population (Thousand), 2016
  2020
• Figure 11 3 Switzerland Cervical Cancer HPV
  DNA Test Population (Thousand), 2008 2015
• Figure 11 4 Switzerland Forecast for Cervical
  Cancer HPV DNA Test Population (Thousand), 2016
  2020
• Figure 11 5 Switzerland Cervical Cancer
  Mortality (Number), 2001 2011
• Figure 11 6 Switzerland Cervical Cancer Test
  Market (Million US), 2008 2015
• Figure 11 7 Switzerland Forecast for Cervical
  Cancer Test Market (Million US), 2016 2020
• Figure 11 8 Switzerland Pap Smear Test Market
  (Million US), 2008 2015
• Figure 11 9 Switzerland Forecast for Pap Smear
  Test Market (Million US), 2016 2020
• Figure 11 10 Switzerland HPV DNA Test Market
  (Million US), 2008 2015
• Figure 11 11 Switzerland Forecast for HPV DNA
  Test Market (Million US), 2016 2020

23
Continue (www.renub.com)

• Figure 12 1 Norway Cervical Cancer Pap Smear
  Test Population (Thousand), 2008 2015
• Figure 12 2 Norway Forecast for Cervical
  Cancer Pap Smear Test Population (Thousand), 2016
  2020
• Figure 12 3 Norway Cervical Cancer HPV DNA
  Test Population (Thousand), 2008 2015
• Figure 12 4 Norway Forecast for Cervical
  Cancer HPV DNA Test Population (Thousand), 2016
  2020
• Figure 12 5 Norway Cervical Cancer Mortality
  (Number), 2001 2011
• Figure 12 6 Norway Cervical Cancer Test Market
  (Million US), 2008 2015
• Figure 12 7 Norway Forecast for Cervical
  Cancer Test Market (Million US), 2016 2020
• Figure 12 8 Norway Pap Smear Test Market
  (Million US), 2008 2015
• Figure 12 9 Norway Forecast for Pap Smear Test
  Market (Million US), 2016 2020
• Figure 12 10 Norway HPV DNA Test Market
  (Million US), 2008 2015
• Figure 12 11 Norway Forecast for HPV DNA Test
  Market (Million US), 2016 2020

24
Continue (www.renub.com)

• Figure 13 1 Netherlands Cervical Cancer Pap
  Smear Test Population (Thousand), 2008 2015
• Figure 13 2 Netherlands Forecast for Cervical
  Cancer Pap Smear Test Population (Thousand), 2016
  2020
• Figure 13 3 Netherlands Cervical Cancer HPV
  DNA Test Population (Thousand), 2008 2015
• Figure 13 4 Netherlands Forecast for Cervical
  Cancer HPV DNA Test Population (Thousand), 2016
  2020
• Figure 13 5 Netherlands Cervical Cancer
  Mortality (Number), 2001 2011
• Figure 13 6 Netherlands Cervical Cancer Test
  Market (Million US), 2008 2015
• Figure 13 7 Netherlands Forecast for Cervical
  Cancer Test Market (Million US), 2016 2020
• Figure 13 8 Netherlands Pap Smear Test Market
  (Million US), 2008 2015
• Figure 13 9 Netherlands Forecast for Pap Smear
  Test Market (Million US), 2016 2020
• Figure 13 10 Netherlands HPV DNA Test Market
  (Million US), 2008 2015
• Figure 13 11 Netherlands Forecast for HPV DNA
  Test Market (Million US), 2016 2020

25
Continue (www.renub.com)

• List of Tables
• Table 25 3 Worldwide Prevalence (Percent) of
  Young Women (1544 Years) who Have Sex before the
  Age of 15 Years, 1994 2006
• Table 25 4 Worldwide HPV Prevalence (Percent)
  among Women with Normal Cervical Cytology, 2010

26
Order Form
Scan and e-mail this page to info_at_renub.com,
alternatively one can also write the Contact
Information in an e-mail and mail it.
Questions? Please call
1-678-302-0700 (USA)
91-120-421-9822 (India), 91-120-424-9780
or mail to info_at_renub.com
27
Format
Report Title Europe Cervical Cancer Test Market,
Patients, By Screening Type (Pap Smear, HPV DNA)
(United Kingdom, France, Germany, Italy, Spain,
Sweden, Switzerland, Norway, Netherlands)

Order online by Credit Card (Visa, MasterCard,
etc.) http//www.renub.com/europe-cervical-cancer
-test-market-patients-by-screening-type-pap-smear-
hpv-dna-united-kingdom-france-germany-italy-spain-
sweden-switzerland-norway-netherlands-989-p.php
Single User (Email from Publisher) Hard Copy (Mail Delivery) CD Rom (Mail Delivery) Global Site License (Multiple User License)
US 1250 US 1350 US 1400 US 2050
28
Order by Check

• Please post the check accompanied by this form,
  to
• Company Address Renub Research
• 1st Floor,
• C-86, Sector-10
• Noida - 201301
• Uttar Pradesh
• India
• Phone
  91-120-421-9822, 424-9780
• For free Sample copy report or to view any of our
  sample work please contact us at info_at_renub.com
  or call 91-120-421-9822 (India), 1-678-302-0700
  (USA)

29
Contact Information for Order by Check
  First Name
Last Name Email Job Title
Company Address City Postal/Zip Code
Country Phone Mobile Fax Report
Format Your message